Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States
- PMID: 35313073
- PMCID: PMC9544683
- DOI: 10.1002/lt.26457
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States
Abstract
Static cold preservation remains the cornerstone for storing donor livers following procurement; however, the choice between University of Wisconsin solution (UW) and histidine-tryptophan-ketoglutarate solution (HTK) remains controversial. Recent International Liver Transplantation Society (ILTS) guidelines have recommended avoiding HTK for donation after circulatory death (DCD) grafts based on older reports. We studied the latest US adult graft outcomes in three recent eras (2006-2010, 2011-2015, 2016-2020) comparing HTK and UW among 5956 DCD LTs: 3873 (65.0%) used UW and 1944 (32.7%) used HTK. In a total of 82,679 donation after brain death (DBD) liver transplantations (LTs), 63,511 (76.8%) used UW and 15,855 (19.2%) used HTK. The HTK group had higher 1-year and 5-year graft survival rates of 89.7% and 74.3%, respectively, compared with 85.9% and 70.8% in the UW group in the 2016-2020 era (p = 0.005). This difference remained when adjusted for important potential confounders (hazard ratio, 0.78; 95% confidence interval: 0.60, 0.99). There were no differences between groups among DCD LTs in the earlier eras or among DBD LTs in all eras (all p values > 0.05). The latest US data suggest that HTK is at least noninferior to UW for preserving DCD livers. These data support HTK use in DCD LT and contradict ILTS guidance.
© 2022 The Authors. Liver Transplantation published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Conflict of interest statement
Thomas G. Cotter, Matthew A. Odenwald, Angelica Perez‐Gutierrez, Kumar Jayant, Diego DiSabato, and John Fung have no relevant disclosures. Michael Charlton has received grant/research support and consultant fees from Gilead, received grant/research support from Conatus and Galectin and consultant fees from Metacrine, Enterome, Novartis, AbbVie, Intercept, and NGM Biopharmaceuticals.
Figures
Comment in
-
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation.Liver Transpl. 2022 Sep;28(9):1423-1424. doi: 10.1002/lt.26528. Epub 2022 Jul 4. Liver Transpl. 2022. PMID: 35706126 No abstract available.
References
-
- van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes Cerisuelo M, Darwish Murad S, et al. Hypothermic machine perfusion in liver transplantation—a randomized trial. N Engl J Med. 2021;384:1391–401. - PubMed
-
- Burra P, Zanetto A, Russo FP, Germani G. Organ preservation in liver transplantation. Semin Liver Dis. 2018;38:260–9. - PubMed
-
- Feng LI, Zhao NA, Yao X, Sun X, Du L, Diao X, et al. Histidine‐tryptophan‐ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl. 2007;13:1125–36. - PubMed
-
- Hessheimer AJ, Polak W, Antoine C, Dondero Pozzo F, Maluf D, Monbaliu D, et al. Regulations and procurement surgery in DCD liver transplantation: expert consensus guidance from the International Liver Transplantation Society. Transplantation. 2021;105:945–51. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
